MarketInOut Stock Screener Log In | Sign Up

DBV Technologies

PAR • Healthcare • Biotechnology • Quote as of 10/30/2026
DBV Technologies stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization563.12 mln
Float273 mln
Earnings Date10/28/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

95 / 100
Top performer

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-3,121%
Severely loss-making

ROE

-129
Deeply negative

ROA

-89.66
Deeply negative

Business Description

DBV Technologies is a French medical research company focused on developing patch-based treatments for food allergies. Its leading program, Viaskin Peanut, has completed a major clinical trial for peanut allergy treatment, while Viaskin Milk is being studied for cow's milk allergy in earlier-stage trials. The company also works with Nestlé Health Science to develop a diagnostic patch test for milk protein allergy in young children. Founded in 2002 and based near Paris, DBV Technologies continues to explore its skin-patch technology as a potential solution for a range of food-related allergic conditions.

Key Fundamentals

EPS-0.60
ROE-129
RPS0.01
ROIC-537
ROA-89.66
EBITDA, mln-139
EV / EBITDA-6.52
EV / EBIT-5.85
Revenue, mln5.13

Quote Details

Last 1.70
Change -0.12 (-6.59%)
Open 1.81
Volume 988,840
Turnover 1,681,028
Average Volume 1,245,106

Financial Ratios

Pre-Tax Profit Margin-3,121
Leverage Ratio1.39
Current Ratio3.72
Price / Book4.38
Price / Tangible Book4.41
Debt / Equity0.13
Price / Sales59.02

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.16% 25 / 100   
1 Month -13.27% 11 / 100   
2 Months -28.27% 7 / 100   
6 Months -49.4% 4 / 100   
1 Year -35.11% 13 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog